Soleno Therapeutics, Inc. · NASDAQ:SLNO
Adage Capital Partners Gp, L.L.C. reported a 6.44% stake in Soleno Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Adage Capital Partners Gp, L.L.C. reported a 6.44% stake in Soleno Therapeutics, Inc., 2,775,976 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 6.44%
- Shares
- 2,775,976
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 6.44% | 2,775,976 |
| Adage Capital Partners GP, L.L.C. | 0% | 0 |
| Robert Atchinson | 6.44% | 2,775,976 |
| Phillip Gross | 6.44% | 2,775,976 |
Source
Related
- Soleno Therapeutics, Inc.
- Adage Capital Partners Gp, L.L.C.
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026